Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Haemonetics (HAE) Long-Term Debt Issuances (2018 - 2025)

Haemonetics has reported Long-Term Debt Issuances over the past 4 years, most recently at -$700.0 million for Q1 2025.

  • Quarterly results put Long-Term Debt Issuances at -$700.0 million for Q1 2025, down 736.36% from a year ago — trailing twelve months through Dec 2025 was -$700.0 million (down 186.42% YoY), and the annual figure for FY2024 was $110.0 million, down 60.71%.
  • Long-Term Debt Issuances for Q1 2025 was -$700.0 million at Haemonetics, down from $700.0 million in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for HAE hit a ceiling of $700.0 million in Q2 2024 and a floor of -$700.0 million in Q1 2025.
  • Median Long-Term Debt Issuances over the past 3 years was $170.0 million (2023), compared with a mean of $85.0 million.
  • Biggest five-year swings in Long-Term Debt Issuances: plummeted 52.17% in 2024 and later tumbled 736.36% in 2025.
  • Haemonetics' Long-Term Debt Issuances stood at $230.0 million in 2023, then soared by 204.35% to $700.0 million in 2024, then tumbled by 200.0% to -$700.0 million in 2025.
  • The last three reported values for Long-Term Debt Issuances were -$700.0 million (Q1 2025), $700.0 million (Q2 2024), and $110.0 million (Q1 2024) per Business Quant data.